With a plan of building a premier innovative biopharma company and now a highly diversified portfolio, Bristol-Myers Squibb’s merger deal with Celgene is expected to become...
The biotech industry is a lucrative business with a focus on curing people. Biotechnology’s development of drugs to treat diseases comes with risks but also with...